Synthesis of sialoglycopolypeptide for potentially blocking influenza virus infection using a rat α2,6-sialyltransferase expressed in BmNPV bacmid-injected silkworm larvae.
Ogata M, Nakajima M, Kato T, Obara T, Yagi H, Kato K, Usui T, Park EY*.
BMC Biotechnology, 9, 54 (2009).
Chemoenzymatic synthesis of sialoglycopolypeptides as glycomimetics to block infection by avian and human influenza viruses.
Ogata M, Hidari KI, Murata T, Shimada S, Kozaki W, Park EY, Suzuki T, Usui T*.
Bioconjugate Chemistry, 20(3), 538-549 (2009).
Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection.
Hidari KI*, Murata T, Yoshida K, Takahashi Y, Minamijima Y, Miwa Y, Adachi S, Ogata M, Usui T, Suzuki Y, Suzuki T.
Glycobiology, 18(10), 779-788 (2008).
日本糖質学会 第11回日本糖質学会ポスター賞（2007年）
尾形慎
Application of γ-glutamic acid polymer produced by Bacillus subtilis var natto for anti-influenza virus agents.
Hidari KI*, Shimada S, Tanaka Y, Minamijima Y, Yoshida K, Ogata M, Murata T, Usui T, Suzuki Y, Suzuki T.
YAKUGAKU ZASSHI, 127, 117-119 (2007).
GlycoWord: Retrospects for future prospects.
Kitajima K, Sugahara K, Hagiya E, Shibuya N, Yoshida K, Ogawa H, Harada Y, Yagi H, Ogata M, Hattori T.
Trends in Glycoscience and Glycotechnology, 19(108), 211-224 (2007).
Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses.
Ogata M, Murata T, Murakami K, Suzuki T, Hidari KI, Suzuki Y, Usui T*.
Bioorganic & Medicinal Chemistry, 15(3), 1383-1393 (2007).
Substrate specificity of N-acetylhexosaminidase from Aspergillus oryzae to artificial glycosyl acceptors having various substituents at the reducing ends.
Ogata M, Zeng X, Usui T, Uzawa H*.
Carbohydrate Research, 342(1), 23-30 (2007).
日本農芸化学会 中部支部維持会員賞（2006年）
尾形慎
